Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
In a recent study posted to the medRxiv* preprint server, researchers identified a wide variety of pathogenic organisms using plasma microbial cell-free deoxyribonucleic acid (mcfDNA) sequencing. Study: Plasma Microbial Cell-free DNA Sequencing from Over 15,000 Patients Identified a Broad Spectrum…
In a recent study posted to the medRxiv* preprint server, researchers assessed the immunogenicity of a variant-adapted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant protein vaccine boosted with an AS03 adjuvant. Study: Safety and immunogenicity of a variant-adapted SARS-CoV-2…
With advances in molecular biology informing recent developments in vaccinology, gene therapy, and other fields of medicine, human adenoviruses (HAdVs) have been of primary importance in medical research. A recent review in Trends in Molecular Medicine looks at the promises…
A study published by The BMJ today sheds further light on the risk of developing a very rare blood-clotting condition known as thrombosis with thrombocytopenia syndrome (TTS) after vaccination against the covid-19 virus. Based on health data from five European…
In a recent study published on the medRxiv* preprint server, Taiwanese scientists determined the risk of myocarditis and pericarditis among young individuals who have received messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccines. Study: Risk of Myocarditis and Pericarditis Following…
In a recent study posted to the medRxiv* preprint server, researchers assessed the association between indoor air respiratory pathogens and natural ventilation, carbon dioxide (CO2) levels, and air filtration. Study: Natural ventilation, low CO2 and air filtration are associated with…
In a recent study posted to the medRxiv* preprint server, researchers assessed immune responses to homologous and heterologous coronavirus disease 2019 (COVID-19) vaccine combinations among Córdoba, Spain, residents. Several vaccines have shown efficacy against SARS-CoV-2; however, the comparative effectiveness of…
The world’s first nasal vaccine for COVID-19 was approved Tuesday, Sept. 6, in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University in St. Louis and developed in collaboration with Bharat Biotech International…
In a recent review published in The New England Journal of Medicine, researchers summarized existing data on the immunogenicity of coronavirus disease 2019 (COVID-19) vaccines and the humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Study:…
In a recent case report posted to the Research Square* preprint server, scientists showed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provokes immunoglobulin A (IgA)-associated vasculitis (IgAV). Study: Infection of SARS-COV2 as a trigger for IgA-associated vasculitis. Image Credit:…
